Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
39 hedge funds and large institutions have $13.5M invested in Enzo Biochem, Inc. in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 41 → 39 (-2)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
23% less capital invested
Capital invested by funds: $17.6M → $13.5M (-$4.06M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
+$86.7K |
| 2 |
Renaissance Technologies
New York
|
+$72.6K |
| 3 |
Lazard Asset Management
New York
|
+$56.8K |
| 4 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$55.3K |
| 5 |
Millennium Management
New York
|
+$21.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.6M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$355K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$107K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30.8K |
| 5 |
TPA
Trivium Point Advisory
Westport,
Connecticut
|
-$24.8K |
ENZ Hedge Fund Activity: Q2 2024 in Review
39 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2024, worth a combined $13.5M — down 23% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ENZ and 4 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Nierenberg Investment Management Company, adding an estimated $86.7K. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.6M sold.
- 39 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2024, down from 41 in Q1 2024.
- Funds reported $13.5M of Enzo Biochem, Inc. stock for Q2 2024, down 23% quarter-over-quarter.
- 4 funds opened new Enzo Biochem, Inc. positions in Q2 2024 and 6 closed out, a net change of -2 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2024 was Nierenberg Investment Management Company, an estimated $86.7K added.
- The largest Enzo Biochem, Inc. seller in Q2 2024 was Tang Capital Management, an estimated $1.6M sold.
Based on aggregated 13F filings for Q2 2024.